SCHEMBL6849570

SCHEMBL6849570

Cc1cccc(-c2cccc(C(=O)O)c2O)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HNF4A P41235 1/20 0.69
AKR1C2 P52895 2/20 0.57
AKR1C1 Q04828 2/20 0.57
ALDH1A1 P00352 2/20 0.53
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
POLB P06746 2/20 0.51
CNR2 P34972 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
MYC P01106 1/20 0.49
LDHA P00338 1/20 0.48
LDHB P07195 1/20 0.48
CNR1 P21554 1/20 0.48
PTPN1 P18031 1/20 0.47
MCL1 Q07820 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
AKR1C3 P42330 1/20 0.45
ALB P02768 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30361685 0.86 L3MBTL1 (0.59) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL268963 0.86 L3MBTL1 (0.59) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL16247702 0.86 AKR1C2 (0.65) HNF4AAKR1C2AKR1C1ALDH1A1HPGD
SCHEMBL16247703 0.85 AKR1C2 (0.51) HNF4AAKR1C2AKR1C1ALDH1A1HPGD
SCHEMBL2533619 0.83 HNF4A (0.79) HNF4AAKR1C2AKR1C1ALDH1A1L3MBTL1
SCHEMBL73041 0.82 HNF4A (1.00) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL29662951 0.82 HNF4A (1.00) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL388293 0.81 NR1H4 (0.59) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL5964729 0.80 HNF4A (0.96) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E
SCHEMBL28302531 0.80 HNF4A (0.96) HNF4AAKR1C2AKR1C1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238637-B2 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof BEIJING BETTA PHARMACEUTICALS CO., LTD (CN) 2016-01-19 US disclosed
US-9238637-B2 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof BEIJING BETTA PHARMACEUTICALS CO., LTD (CN) 2016-01-19 US disclosed
US-20140343137-A1 Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-11-20 US disclosed
US-20140343137-A1 Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-11-20 US disclosed
EP-1294378-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2004-01-28 EP disclosed
EP-1294378-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-26 EP disclosed
WO-2001089457-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343137-A1 Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof HIF1A, HIF1AN, COXFA4L2 HNF4A 749/4885AKR1C2 497/4885AKR1C1 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.